Novel immune signals and atherosclerosis

Area of Science:

• Cardiovascular Research
• Immunology
• Molecular Biology

Background:

• Atherosclerosis is the primary cause of coronary artery disease (CAD) and cerebrovascular disease, leading causes of mortality.
• Cardiovascular disease risk is reduced by controlling risk factors, notably lowering low-density lipoprotein (LDL) cholesterol with statins.
• Atherosclerosis is characterized as a chronic inflammatory condition initiated by risk factors, leading to endothelial dysfunction and inflammatory cell infiltration.

Purpose of the Study:

• To review the molecular mechanisms of immune signaling in atherosclerosis development and progression.
• To discuss the role of toll-like receptors (TLRs) in the pathogenesis of atherosclerosis.
• To explore monocyte/macrophage biology, including polarization and heterogeneity, in atherosclerosis progression.

Main Methods:

• Literature review summarizing current understanding of molecular mechanisms.
• Focus on immune signals, specifically toll-like receptors (TLRs).
• Analysis of monocyte/macrophage biology, including polarization and heterogeneity.

Main Results:

• Toll-like receptors (TLRs) are identified as potent inducers of inflammation and play a significant role in atherosclerosis pathogenesis.
• Monocyte and macrophage biology, encompassing polarization and heterogeneity, significantly contributes to atherosclerosis progression.
• Current knowledge highlights the interplay between molecular mechanisms and immune cell behavior in atherosclerosis.

Conclusions:

• Understanding the molecular mechanisms and immune cell orchestration is crucial for developing novel therapeutic strategies.
• Targeting immune pathways and monocyte/macrophage behavior offers potential for preventing and treating atherosclerosis.
• Further research into TLRs and macrophage dynamics can lead to innovative treatments for cardiovascular disorders.